18th Jun 2021 11:15
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 17 June 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
414,093 | 10.5500 GBP | 10.4600 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
22,751 255,882 | N/A 10.5783 GBP | N/A 10.4659 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
| 35 3,076 20,593 3,733 14 5,495 2,580 1,056 6,845 47,117 422 4,134 11,815 501 242 304 4,249
1,099 129,099
83 59 1,720 9,016 11,853 2,925 27,160 18,286
5,292 3,738 50,000 187,500 | 10.4701 GBP 10.4753 GBP 10.4759 GBP 10.4794 GBP 10.4800 GBP 10.4803 GBP 10.4866 GBP 10.4903 GBP 10.4976 GBP 10.5000 GBP 10.5005 GBP 10.5010 GBP 10.5031 GBP 10.5128 GBP 10.5150 GBP 10.5201 GBP 10.5420 GBP
10.4799 GBP 10.4812 GBP
10.4659 GBP 10.4692 GBP 10.4700 GBP 10.4794 GBP 10.4819 GBP 10.4998 GBP 10.5000 GBP 10.5251 GBP
10.4848 GBP 10.5078 GBP 10.5105 GBP 10.5479 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 18 June 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L